| 1 |
34607551 | Role of SCN2A c.56G/A Gene Polymorphism in Egyptian Children with Genetic Epilepsy with Febrile Seizure Plus. | 2022 |
1 |
| 2 |
34808247 | The diffuse distribution of Nav1.2 on mid-axonal regions is a marker for unmyelinated fibers in the central nervous system. | 2022 Apr |
2 |
| 3 |
34874093 | A mutation in the neonatal isoform of SCN2A causes neonatal-onset epilepsy. | 2022 Mar |
1 |
| 4 |
35136380 | Genetic Analysis of Sodium Channel Genes in Pediatric Epilepsy Patients of Pakistan. | 2022 |
1 |
| 5 |
35200683 | Computational Design of High-Affinity Blockers for Sodium Channel NaV1.2 from μ-Conotoxin KIIIA. | 2022 Feb 21 |
1 |
| 6 |
35348308 | Commonalities and distinctions between two neurodevelopmental disorder subtypes associated with SCN2A and SCN8A variants and literature review. | 2022 May |
1 |
| 7 |
35417276 | SCN2A-related epilepsy of infancy with migrating focal seizures: report of a variant with apparent gain- and loss-of-function effects. | 2022 May 1 |
2 |
| 8 |
32737897 | Drug-drug and drug-food interactions in an infant with early-onset SCN2A epilepsy treated with carbamazepine, phenytoin and a ketogenic diet. | 2021 Mar |
1 |
| 9 |
33369088 | Generation and basic characterization of a gene-trap knockout mouse model of Scn2a with a substantial reduction of voltage-gated sodium channel Nav 1.2 expression. | 2021 Apr |
2 |
| 10 |
33460646 | Cryptic prokaryotic promoters explain instability of recombinant neuronal sodium channels in bacteria. | 2021 Jan-Jun |
1 |
| 11 |
33779092 | Ketogenic Diet in Infants with Early-Onset Epileptic Encephalopathy and SCN2A Mutation. | 2021 Apr |
1 |
| 12 |
33901038 | A De Novo Missense Variant of SCN2A: Implications and Limitations for Understanding Clinical Phenotype and Treatment Recommendations. | 2021 Jul-Aug 01 |
1 |
| 13 |
34093402 | Differential Functional Changes of Nav1.2 Channel Causing SCN2A-Related Epilepsy and Status Epilepticus During Slow Sleep. | 2021 |
2 |
| 14 |
34287911 | Enhanced slow inactivation contributes to dysfunction of a recurrent SCN2A mutation associated with developmental and epileptic encephalopathy. | 2021 Sep |
2 |
| 15 |
34348157 | Paradoxical hyperexcitability from NaV1.2 sodium channel loss in neocortical pyramidal cells. | 2021 Aug 3 |
2 |
| 16 |
34373125 | The NaVy paradox: reducing sodium currents increases excitability. | 2021 Oct |
1 |
| 17 |
34416509 | Quinazolinone dimers as a potential new class of safer Kv1 inhibitors: Overcoming hERG, sodium and calcium channel affinities. | 2021 Oct |
1 |
| 18 |
34425903 | Developmental dynamics of voltage-gated sodium channel isoform expression in the human and mouse brain. | 2021 Aug 23 |
1 |
| 19 |
34716231 | Hyperexcitability and Pharmacological Responsiveness of Cortical Neurons Derived from Human iPSCs Carrying Epilepsy-Associated Sodium Channel Nav1.2-L1342P Genetic Variant. | 2021 Dec 8 |
3 |
| 20 |
31734278 | Elevated ocular pressure reduces voltage-gated sodium channel NaV1.2 protein expression in retinal ganglion cell axons. | 2020 Jan |
1 |
| 21 |
31995133 | Alternative splicing potentiates dysfunction of early-onset epileptic encephalopathy SCN2A variants. | 2020 Mar 2 |
3 |
| 22 |
32244818 | Differential Inhibition of Human Nav1.2 Resurgent and Persistent Sodium Currents by Cannabidiol and GS967. | 2020 Apr 1 |
1 |
| 23 |
32264956 | SCN2A channelopathies in the autism spectrum of neuropsychiatric disorders: a role for pluripotent stem cells? | 2020 Apr 7 |
2 |
| 24 |
32480218 | Parabens inhibit hNaV 1.2 channels. | 2020 Aug |
1 |
| 25 |
32603808 | Neonatal SCN2A encephalopathy: A peculiar recognizable electroclinical sequence. | 2020 Oct |
3 |
| 26 |
32750235 | Functional and pharmacological evaluation of a novel SCN2A variant linked to early-onset epilepsy. | 2020 Sep |
1 |
| 27 |
33000761 | The phenotype and treatment of SCN2A-related developmental and epileptic encephalopathy. | 2020 Oct 1 |
1 |
| 28 |
31186137 | Cilia function is associated with axon initial segment morphology. | 2019 Aug 13 |
1 |
| 29 |
31558572 | Resurgent and Gating Pore Currents Induced by De Novo SCN2A Epilepsy Mutations. | 2019 Sep/Oct |
1 |
| 30 |
31718537 | An integrative methodology based on protein-protein interaction networks for identification and functional annotation of disease-relevant genes applied to channelopathies. | 2019 Nov 12 |
1 |
| 31 |
31803246 | The Identification of Differentially Expressed Genes Showing Aberrant Methylation Patterns in Pheochromocytoma by Integrated Bioinformatics Analysis. | 2019 |
1 |
| 32 |
31904120 | SCN2A channelopathies: Mechanisms and models. | 2019 Dec |
2 |
| 33 |
31966371 | De novo SCN2A mutation in a Chinese infant with severe early-onset epileptic encephalopathy, bronchopulmonary dysplasia, and adrenal hypofunction. | 2017 |
2 |
| 34 |
18242854 | Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy. | 2008 Mar 5 |
1 |
| 35 |
16417554 | A novel SCN2A mutation in family with benign familial infantile seizures. | 2006 Jan |
1 |
| 36 |
15651314 | [Molecular genetics of epilepsy]. | 2004 Nov |
1 |
| 37 |
12243921 | Sodium-channel defects in benign familial neonatal-infantile seizures. | 2002 Sep 14 |
1 |